JBM (Healthcare) Limited (HKG:2161)
1.625
+0.030 (1.88%)
Oct 9, 2026, 4:08 PM HKT
JBM (Healthcare) Market Cap
JBM (Healthcare) has a market cap or net worth of 1.33 billion as of October 9, 2026. It is the 21,946th most valuable company in the world and the 1,034th biggest in Hong Kong. Its market cap has decreased by 45.08% in one year.
Market Cap
1.33B
Enterprise Value
1.60B
Revenue
834.63M
Global Rank
Country Rank
#1,034 Hong Kong
PE Ratio
6.60
ChartMarket Cap Chart
Since February 5, 2021, JBM (Healthcare)'s market cap has decreased from 1.93B to 1.33B, a decrease of -30.99%. That is a compound annual growth rate of -6.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.33B | -38.72% |
| Dec 31, 2025 | 2.17B | 40.57% |
| Dec 31, 2024 | 1.55B | 71.27% |
| Dec 29, 2023 | 903.02M | 6.82% |
| Dec 30, 2022 | 845.38M | -8.16% |
| Dec 31, 2021 | 920.50M | -52.31% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CF PharmTech | 2.46B |
| Hua Medicine (Shanghai) | 2.23B |
| VISEN Pharmaceuticals | 2.03B |
| CPBIO Holding Company | 2.01B |
| Jacobson Pharma Corporation | 1.94B |
| Dawnrays Pharmaceutical (Holdings) | 1.45B |
| Golden Throat Holdings Group Company | 1.42B |
| Jilin Province Huinan Changlong Bio-pharmacy Company | 1.36B |